시장보고서
상품코드
1550075

분자 운송 배지 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2032년)

Molecular Transport Medium Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

발행일: | 리서치사: Persistence Market Research | 페이지 정보: 영문 336 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Persistence Market Research는 분자 운송 배지 세계 시장에 대한 종합적인 보고서를 발표했습니다. 이 보고서는 시장 성장 촉진요인, 동향, 기회 및 과제를 포함한 중요한 시장 역학을 철저히 평가하고 시장 구조에 대한 자세한 통찰력을 제공합니다.

주요 인사이트

  • 분자 운송 배지 시장 규모(2024E) : 11억 4,700만 달러
  • 시장 예측치(2032F) :12억 7,200만 달러
  • 세계 시장 성장률(CAGR 2024년부터 2032년까지) : 1.3%

분자 운송 배지 시장-보고 범위:

분자 운송 배지는 특히 감염의 진단 검사를 위한 임상 표본의 보존과 수송에 중요한 역할을 합니다. 이 배지는 정확한 분자 분석을 위해 RNA와 DNA 샘플의 무결성을 유지하도록 특별히 설계되었으며 다양한 질병을 진단하는 데 도움이 됩니다. 분자 운송 배지 시장은 병원, 진단 실험실, 조사 기관, 생명 공학 기업에 서비스를 제공하며 바이러스, 박테리아 및 범용 운송 배지를 포함한 다양한 수송 솔루션을 제공합니다. 시장 성장의 원동력은 진단 검사 수요 증가, 감염증 유행 증가, 분자진단 기술의 진보에 의한 시료 보존 및 수송 효율의 향상입니다.

시장 성장 촉진요인:

세계의 분자 운송 배지 시장은 정확한 진단 검사, 특히 COVID-19, 인플루엔자 및 기타 신흥 병원체와 같은 바이러스 감염에 대한 요구 증가와 같은 몇 가지 중요한 요인에 의해 추진되고 있습니다. 전염병의 세계 유행과 그에 따른 분자진단을 위한 신뢰할 수 있는 운송 솔루션에 대한 수요가 증가함에 따라 시장 확대가 더욱 강화되고 있습니다. 바이러스 불활성화 운송 배지 개발 및 시료 보존 기술 강화와 같은 기술적 진보는 진단 검사의 정확성을 향상시키고 오염 위험을 줄이고 시장 성장을 가속하고 있습니다. 게다가, 유전체학와 맞춤형 의료에서의 연구개발 활동에 대한 주목 증가는 첨단 분자검사에 특화된 운송 배지를 제공하는 시장참가자에게 새로운 기회를 가져오고 있습니다.

시장 성장 억제요인:

유망한 성장 전망에도 불구하고, 분자 운송 배지 시장은 규정 준수, 공급망 혼란, 비용 제약과 관련된 문제에 직면하고 있습니다. 운송 매체의 제조, 운송 및 사용을 규정하는 엄격한 규제는 제조업체에 컴플라이언스에 부담을 주어 시장 진입 장벽 및 운영 비용에 영향을 미칩니다. 게다가, 특히 세계 보건 보건 긴급 상황에서는 공급망 문제가 중요한 운송 매체 부족으로 이어져 진단 검사 능력에 영향을 미칠 수 있습니다. 특수 분자 운송 배지의 비용이 높고 이용 가능한 지역이 제한되어 있는 것은 특히 의료 예산에 제약이 있는 신흥 경제국에서 시장 침투의 과제가 되고 있습니다. 이러한 규제 및 물류 장벽을 해결하기 위해서는 안전하고 효과적인 운송 솔루션의 지속적인 공급을 보장하기 위해 업계 이해 관계자와 정책 입안자의 협력이 필요합니다.

시장 기회:

분자 운송 배지시장은 기술 혁신, 조사활동 확대, 헬스케어 제공 모델의 진화를 원동력으로 하는 큰 성장 기회를 제시하고 있습니다. 자동화된 시료 취급과 운송 기술의 통합은 실험실의 효율성을 높이고 진단 워크플로우에서 인위적인 실수를 줄여줍니다. 게다가, 맞춤형 의료 및 유전체학 연구에 있어서의 분자 운송 배지의 응용 확대가 시장의 범위를 넓혀 기술 혁신을 자극하고 있습니다. 전략적 파트너십, R&D 투자, 비용 효율적인 운송 솔루션의 도입은 새로운 기회를 활용하고 역동적인 분자 운송 랜드스케이프에서 시장의 리더십을 유지하는 데 필수적입니다.

이 보고서에서 다루는 주요 질문

  • 분자 운송 배지 시장의 세계 성장을 가속하는 주요 요인은 무엇인가?
  • 어떤 운송 매체의 유형과 용도가 다양한 헬스케어 환경에서의 채용을 촉진하고 있는가?
  • 기술 진보는 분자 운송 배지 시장 경쟁 구도를 어떻게 바꾸고 있는가?
  • 분자 운송 배지 시장에 기여하는 주요 기업은 누구이며 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
  • 세계의 분자 운송 배지 시장에서의 새로운 동향과 전망은?

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 범위/분류
  • 시장의 정의/범위/제한
  • 포함과 제외

제3장 주요 시장 동향

  • 시장에 영향을 주는 주요 동향
  • 제품 혁신/개발 동향

제4장 주요 내용

  • 제품 채용 분석
  • 제조업체가 채용한 주요 전략
  • 규제 시나리오
  • PESTLE 분석
  • Porter's Five Forces 분석
  • 밸류체인 분석

제5장 시장 배경

  • 거시경제 요인
  • 예측 요인- 관련성과 영향
  • 시장 역학

제6장 COVID-19 위기 분석

  • 2024년 시장 시나리오
  • COVID-19와 영향 분석
    • 제품 유형
    • 용도별
    • 샘플별
    • 최종 사용자별
    • 지역별

제7장 세계 분자 운송 배지 시장 - 가격 분석

  • 세계 평균 가격 분석 벤치마크
  • 가격의 상정

제8장 세계의 분자 운송 배지 시장 수요(가치 또는 규모, 10억 달러) 분석

  • 시장 매출(10억 달러) 분석, 2019-2023년
  • 시장 매출(10억 달러) 예측, 2024-2032년
    • 전년대비 성장 동향 분석
    • 절대 수익 기회

제9장 제품 유형별: 세계의 분자 운송 배지 시장 분석

  • 소개/주요 조사 결과
  • 시장 규모(10억 달러) 분석, 2019-2023년
  • 시장 규모(10억 달러) 분석과 예측, 2024-2032년
    • 활성화 운송 배지
    • 불활성화 운송 배지

제10장 용도별 : 세계의 분자 운송 배지 시장 분석

  • 소개/주요 조사 결과
  • 시장 규모(10억 달러) 분석, 2019-2023년
  • 시장 규모(10억 달러) 분석과 예측, 2024-2032년
    • 바이러스
      • COVID-19
      • 중동 호흡기 증후군(MERS)
      • 인플루엔자
      • COVID-19
      • 인간 면역결핍 바이러스(HIV)
      • 리노바이러스
      • 아데노바이러스
      • 호흡기 합포체 바이러스(RSV)
    • 박테리아
      • 포도상구균성 폐렴
      • 인플루엔자균
      • 탄저균
      • 기타
    • 비정형 세균
      • 마이코플라스마
      • Q열
      • 기타
    • 결핵균 및 진균 감염

제11장 샘플별: 세계의 분자 운송 배지 시장 분석

  • 소개/주요 조사 결과
  • 시장 규모(10억 달러) 분석, 2019-2023년
  • 시장 규모(10억 달러) 분석과 예측, 2024-2032년
    • 코 세척과 면봉
    • 객담
    • 타액
    • 대번
    • 소변
    • 티슈
    • 기타

제12장 최종 사용자별: 세계의 분자 운송 배지 시장 분석

  • 소개/주요 조사 결과
  • 시장 규모(10억 달러) 분석, 2019-2023년
  • 시장 규모(10억 달러) 분석과 예측, 2024-2032년
    • 진단 실험실
    • 미생물학 연구소
    • 병원 및 클리닉
    • 기타

제13장 지역별: 세계의 분자 운송 배지 시장 분석

  • 소개
  • 시장 규모(10억 달러) 분석, 2019-2023년
  • 시장 규모(10억 달러) 분석과 예측, 2024-2032년
    • 북미
    • 라틴아메리카
    • 유럽
    • 남아시아
    • 동아시아
    • 오세아니아
    • 중동 및 아프리카(중동 및 아프리카)

제14장 북미 분자 운송 배지 시장 분석

제15장 라틴아메리카의 분자 운송 배지 시장 분석

제16장 유럽의 분자 운송 배지 시장 분석

제17장 남아시아 분자 운송 배지 시장 분석

제18장 동아시아의 분자 운송 배지 시장 분석

제19장 오세아니아의 분자 운송 배지 시장 분석

제20장 중동 및 아프리카의 분자 운송 배지 시장 분석

제21장 시장 구조 분석

  • 기업 Tier별 시장 분석
  • 주요 기업의 시장 점유율 분석
  • 시장 집중
  • 시장현재분석

제22장 경쟁 분석

  • 경쟁 대시보드
  • 경쟁 벤치마킹
  • 경쟁의 상세
    • Thermo Fisher Scientific
    • Becton Dickinson and Company
    • Cardinal Health
    • Quidel Corporation
    • Medical Wire &Equipment(MWE)
    • COPAN Diagnostics Inc.(COPAN Group)
    • Titan Biotech Ltd.
    • Alpha Teknova, Inc.(formerly named Teknova)
    • Bio-Genex Laboratories Inc.
    • EKF Diagnostics
    • Trinity Biotech
    • Alpha-Tec Systems, Inc.
    • Charm Sciences, Inc.
    • Azer Scientific
    • bioBoaVista
    • AccuGene
    • KSL Diagnostics
    • Puritan Medical Products
    • Amazing Biotech(Shanghai) Co., Ltd.

제23장 사용된 전제조건과 약어

제24장 조사 방법

JHS 24.10.04

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular transport medium. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Molecular Transport Medium Market Size (2024E): USD 1.147 Billion
  • Projected Market Value (2032F): USD 1.272 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 1.3%

Molecular Transport Medium Market - Report Scope:

Molecular transport medium plays a crucial role in preserving and transporting clinical specimens for diagnostic testing, particularly for infectious diseases. This medium is specifically designed to maintain the integrity of RNA and DNA samples for accurate molecular analysis, aiding in the diagnosis of various conditions. The molecular transport medium market serves hospitals, diagnostic laboratories, research institutions, and biotechnology companies, offering a range of transport solutions, including viral, bacterial, and general-purpose transport mediums. Market growth is driven by the increasing demand for diagnostic testing, rising prevalence of infectious diseases, and advancements in molecular diagnostics technology, enhancing specimen preservation and transportation efficiency.

Market Growth Drivers:

The global molecular transport medium market is propelled by several key factors, including the growing need for accurate diagnostic testing, particularly for viral infections like COVID-19, influenza, and other emerging pathogens. The rising prevalence of infectious diseases globally and the subsequent demand for reliable transport solutions for molecular diagnostics further drive market expansion. Technological advancements, such as the development of viral inactivation transport mediums and enhanced specimen preservation technologies, offer improved accuracy in diagnostic testing and reduce the risk of contamination, fostering market growth. Moreover, the increasing focus on research and development activities in genomics and personalized medicine creates new opportunities for market players to provide specialized transport mediums for advanced molecular testing.

Market Restraints:

Despite promising growth prospects, the molecular transport medium market faces challenges related to regulatory compliance, supply chain disruptions, and cost constraints. Stringent regulations governing the manufacturing, transportation, and use of transport mediums impose compliance burdens on manufacturers, affecting market entry barriers and operational costs. Furthermore, supply chain issues, particularly during global health emergencies, can lead to shortages of critical transport mediums, impacting diagnostic testing capacities. The high cost of specialized molecular transport mediums and limited availability in certain regions pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and logistical barriers requires collaboration between industry stakeholders and policymakers to ensure the continuous supply of safe and effective transport solutions.

Market Opportunities:

The molecular transport medium market presents significant growth opportunities driven by technological innovations, expanding research activities, and evolving healthcare delivery models. The integration of automated specimen handling and transport technologies enhances laboratory efficiency and reduces human error in diagnostic workflows. Furthermore, the growing application of molecular transport mediums in personalized medicine and genomics research broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of cost-effective transport solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic molecular transport landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the molecular transport medium market globally?
  • Which transport medium types and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the molecular transport medium market?
  • Who are the key players contributing to the molecular transport medium market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global molecular transport medium market?

Competitive Intelligence and Business Strategy:

Leading players in the global molecular transport medium market, including Thermo Fisher Scientific, Becton, Dickinson and Company, and COPAN Diagnostics Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced transport mediums, including viral inactivation solutions and enhanced stabilization formulas, catering to diverse diagnostic needs and research requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and customer education fosters market growth and enhances specimen integrity in the rapidly evolving molecular diagnostics landscape.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • COPAN Diagnostics Inc.
  • Puritan Medical Products
  • BioMed Diagnostics
  • Hardy Diagnostics
  • Longhorn Vaccines & Diagnostics
  • Titan Biotech Ltd.
  • Starplex Scientific
  • HiMedia Laboratories

Key Segments Covered in Molecular Transport Medium Industry Research

Molecular Transport Medium Market by Product Type:

  • Active Transport Medium
  • Inactivated Transport Medium

Molecular Transport Medium Market by Application:

  • Virus
  • Bacteria
  • Atypical Bacteria
  • Mycobacterial and Fungal Infection

Molecular Transport Medium Market by Sample:

  • Nasal Washes and Swabs
  • Sputum
  • Saliva
  • Faecal & Stool
  • Urine
  • Blood
  • Tissues

Molecular Transport Medium Market by End User:

  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics

Molecular Transport Medium Market by Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Inclusions

  • 4.1. Product Adoption Analysis
  • 4.2. Key Strategies Adopted by Manufacturers
  • 4.3. Regulatory Scenario
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Global Healthcare Spending Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. COVID-19 Pandemic
    • 5.2.2. Product Launches
    • 5.2.3. GDP Growth
    • 5.2.4. Increasing Prevalence of Infectious Diseases
    • 5.2.5. R&D Expenditure by Key Players
    • 5.2.6. Product Adoption Rate
    • 5.2.7. Regulatory Scenario
    • 5.2.8. Strategic Acquisitions and Mergers among Key Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Sample
    • 6.2.4. By End User
    • 6.2.5. By Region

7. Global Molecular Transport Medium Market- Pricing Analysis

  • 7.1. Global Average Pricing Analysis Benchmark
  • 7.2. Pricing Assumption

8. Global Molecular Transport Medium Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2032

  • 8.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 8.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis

9. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Product Type, 2024-2032
    • 9.3.1. Active Transport Medium
    • 9.3.2. Inactivated Transport Medium

10. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis by Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Application, 2024-2032
    • 10.3.1. Virus
      • 10.3.1.1. COVID-19
      • 10.3.1.2. Middle East respiratory syndrome (MERS)
      • 10.3.1.3. Influenza
      • 10.3.1.4. COVID-19
      • 10.3.1.5. Human Immunodeficiency Virus (HIV)
      • 10.3.1.6. Rhinovirus
      • 10.3.1.7. Adenovirus
      • 10.3.1.8. Respiratory Syncytial Virus (RSV)
    • 10.3.2. Bacteria
      • 10.3.2.1. Staphylococcus pneumonia
      • 10.3.2.2. Haemophilus influenzae
      • 10.3.2.3. Anthrax
      • 10.3.2.4. Others
    • 10.3.3. Atypical Bacteria
      • 10.3.3.1. Mycoplasma
      • 10.3.3.2. Q-Fever
      • 10.3.3.3. Others
    • 10.3.4. Mycobacterial and Fungal Infection

11. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Sample

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Sample, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Sample, 2024-2032
    • 11.3.1. Nasal Washes and Swabs
    • 11.3.2. Sputum
    • 11.3.3. Saliva
    • 11.3.4. Faecal & Stool
    • 11.3.5. Urine
    • 11.3.6. Blood
    • 11.3.7. Tissues
    • 11.3.8. Others

12. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2032
    • 12.3.1. Diagnostic Laboratories
    • 12.3.2. Microbiology Laboratories
    • 12.3.3. Hospitals & Clinics
    • 12.3.4. Others

13. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
  • 13.3. Current Market Size (US$ Bn) Analysis and Forecast by Region, 2024-2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)

14. North America Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product Type
    • 14.3.3. By Application
    • 14.3.4. By Sample
    • 14.3.5. By End User
  • 14.4. Market Trends
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Molecular Transport Medium Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Product Type
        • 14.7.1.2.2. By Application
        • 14.7.1.2.3. By Sample
        • 14.7.1.2.4. By End User
    • 14.7.2. Canada Molecular Transport Medium Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Product Type
        • 14.7.2.2.2. By Application
        • 14.7.2.2.3. By Sample
        • 14.7.2.2.4. By End User

15. Latin America Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product Type
    • 15.3.3. By Application
    • 15.3.4. By Sample
    • 15.3.5. By End User
  • 15.4. Market Trends
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Molecular Transport Medium Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Product Type
        • 15.7.1.2.2. By Application
        • 15.7.1.2.3. By Sample
        • 15.7.1.2.4. By End User
    • 15.7.2. Argentina Molecular Transport Medium Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Product Type
        • 15.7.2.2.2. By Application
        • 15.7.2.2.3. By Sample
        • 15.7.2.2.4. By End User
    • 15.7.3. Mexico Molecular Transport Medium Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Product Type
        • 15.7.3.2.2. By Application
        • 15.7.3.2.3. By Sample
        • 15.7.3.2.4. By End User

16. Europe Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Nordic Countries
      • 16.3.1.8. Russia
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product Type
    • 16.3.3. By Application
    • 16.3.4. By Sample
    • 16.3.5. By End User
  • 16.4. Market Trends
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Molecular Transport Medium Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Product Type
        • 16.7.1.2.2. By Application
        • 16.7.1.2.3. By Sample
        • 16.7.1.2.4. By End User
    • 16.7.2. France Molecular Transport Medium Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Product Type
        • 16.7.2.2.2. By Application
        • 16.7.2.2.3. By Sample
        • 16.7.2.2.4. By End User
    • 16.7.3. Italy Molecular Transport Medium Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Product Type
        • 16.7.3.2.2. By Sample
        • 16.7.3.2.3. By End User
    • 16.7.4. Spain Molecular Transport Medium Market
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Product Type
        • 16.7.4.2.2. By Application
        • 16.7.4.2.3. By Sample
        • 16.7.4.2.4. By End User
    • 16.7.5. U.K. Molecular Transport Medium Market
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Product Type
        • 16.7.5.2.2. By Application
        • 16.7.5.2.3. By Sample
        • 16.7.5.2.4. By End User
    • 16.7.6. BENELUX Union Molecular Transport Medium Market
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Product Type
        • 16.7.6.2.2. By Application
        • 16.7.6.2.3. By Sample
        • 16.7.6.2.4. By End User
    • 16.7.7. Nordic Countries Molecular Transport Medium Market
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Product Type
        • 16.7.7.2.2. By Application
        • 16.7.7.2.3. By Sample
        • 16.7.7.2.4. By End User
    • 16.7.8. Russia Molecular Transport Medium Market
      • 16.7.8.1. Introduction
      • 16.7.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.8.2.1. By Product Type
        • 16.7.8.2.2. By Application
        • 16.7.8.2.3. By Sample
        • 16.7.8.2.4. By End User

17. South Asia Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Vietnam
      • 17.3.1.6. Philippines
      • 17.3.1.7. Rest of South Asia
    • 17.3.2. By Product Type
    • 17.3.3. By Application
    • 17.3.4. By Sample
    • 17.3.5. By End User
  • 17.4. Market Trends
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. India Molecular Transport Medium Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Product Type
        • 17.7.1.2.2. By Application
        • 17.7.1.2.3. By Sample
        • 17.7.1.2.4. By End User
    • 17.7.2. Indonesia Molecular Transport Medium Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Product Type
        • 17.7.2.2.2. By Application
        • 17.7.2.2.3. By Sample
        • 17.7.2.2.4. By End User
    • 17.7.3. Vietnam Molecular Transport Medium Market
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Product Type
        • 17.7.3.2.2. By Application
        • 17.7.3.2.3. By Sample
        • 17.7.3.2.4. By End User
    • 17.7.4. Philippines Molecular Transport Medium Market
      • 17.7.4.1. Introduction
      • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.4.2.1. By Product Type
        • 17.7.4.2.2. By Application
        • 17.7.4.2.3. By Sample
        • 17.7.4.2.4. By End User
    • 17.7.5. Malaysia Molecular Transport Medium Market
      • 17.7.5.1. Introduction
      • 17.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.5.2.1. By Product Type
        • 17.7.5.2.2. By Application
        • 17.7.5.2.3. By Sample
        • 17.7.5.2.4. By End User
    • 17.7.6. Thailand Molecular Transport Medium Market
      • 17.7.6.1. Introduction
      • 17.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.6.2.1. By Product Type
        • 17.7.6.2.2. By Application
        • 17.7.6.2.3. By Sample
        • 17.7.6.2.4. By End User

18. East Asia Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Bn) Forecast by Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product Type
    • 18.3.3. By Application
    • 18.3.4. By Sample
    • 18.3.5. By End User
  • 18.4. Market Trends
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. China Molecular Transport Medium Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Product Type
        • 18.7.1.2.2. By Application
        • 18.7.1.2.3. By Sample
        • 18.7.1.2.4. By End User
    • 18.7.2. Japan Molecular Transport Medium Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Product Type
        • 18.7.2.2.2. By Application
        • 18.7.2.2.3. By Sample
        • 18.7.2.2.4. By End User
    • 18.7.3. South Korea Molecular Transport Medium Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Product Type
        • 18.7.3.2.2. By Application
        • 18.7.3.2.3. By Sample
        • 18.7.3.2.4. By End User

19. Oceania Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 19.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product Type
    • 19.3.3. By Application
    • 19.3.4. By Sample
    • 19.3.5. By End User
  • 19.4. Market Trends
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Molecular Transport Medium Market
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Product Type
        • 19.7.1.2.2. By Application
        • 19.7.1.2.3. By Sample
        • 19.7.1.2.4. By End User
    • 19.7.2. New Zealand Molecular Transport Medium Market
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Product Type
        • 19.7.2.2.2. By Application
        • 19.7.2.2.3. By Sample
        • 19.7.2.2.4. By End User

20. Middle East and Africa (MEA) Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 20.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. Israel
      • 20.3.1.4. North Africa
      • 20.3.1.5. South Africa
      • 20.3.1.6. Rest of Middle East and Africa
    • 20.3.2. By Product Type
    • 20.3.3. By Application
    • 20.3.4. By Sample
    • 20.3.5. By End User
  • 20.4. Market Trends
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Molecular Transport Medium Market
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Product Type
        • 20.7.1.2.2. By Application
        • 20.7.1.2.3. By Sample
        • 20.7.1.2.4. By End User
    • 20.7.2. Israel Molecular Transport Medium Market
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Product Type
        • 20.7.2.2.2. By Application
        • 20.7.2.2.3. By Sample
        • 20.7.2.2.4. By End User
    • 20.7.3. Turkey Molecular Transport Medium Market
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Product Type
        • 20.7.3.2.2. By Application
        • 20.7.3.2.3. By Sample
        • 20.7.3.2.4. By End User
    • 20.7.4. South Africa Molecular Transport Medium Market
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.4.2.1. By Product Type
        • 20.7.4.2.2. By Application
        • 20.7.4.2.3. By Sample
        • 20.7.4.2.4. By End User
    • 20.7.5. North Africa Molecular Transport Medium Market
      • 20.7.5.1. Introduction
      • 20.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.5.2.1. By Product Type
        • 20.7.5.2.2. By Application
        • 20.7.5.2.3. By Sample
        • 20.7.5.2.4. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis
    • 21.4.1. Regional footprint of Players
    • 21.4.2. Product footprint by Players
    • 21.4.3. Channel Foot Print by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Thermo Fisher Scientific
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. Strategy Overview
      • 22.3.1.6. Key Developments
      • 22.3.1.7. SWOT Analysis
    • 22.3.2. Becton Dickinson and Company
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. Strategy Overview
      • 22.3.2.6. Key Developments
      • 22.3.2.7. SWOT Analysis
    • 22.3.3. Cardinal Health
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. Strategy Overview
      • 22.3.3.6. Key Developments
      • 22.3.3.7. SWOT Analysis
    • 22.3.4. Quidel Corporation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. Strategy Overview
      • 22.3.4.6. Key Developments
      • 22.3.4.7. SWOT Analysis
    • 22.3.5. Medical Wire & Equipment (MWE)
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. Strategy Overview
      • 22.3.5.6. Key Developments
      • 22.3.5.7. SWOT Analysis
    • 22.3.6. COPAN Diagnostics Inc. [COPAN Group]
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. Strategy Overview
      • 22.3.6.6. Key Developments
      • 22.3.6.7. SWOT Analysis
    • 22.3.7. Titan Biotech Ltd.
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. Strategy Overview
      • 22.3.7.6. Key Developments
      • 22.3.7.7. SWOT Analysis
    • 22.3.8. Alpha Teknova, Inc. [formerly named Teknova]
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. Strategy Overview
      • 22.3.8.6. Key Developments
      • 22.3.8.7. SWOT Analysis
    • 22.3.9. Bio-Genex Laboratories Inc.
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. Strategy Overview
      • 22.3.9.6. Key Developments
      • 22.3.9.7. SWOT Analysis
    • 22.3.10. EKF Diagnostics
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. Strategy Overview
      • 22.3.10.6. Key Developments
      • 22.3.10.7. SWOT Analysis
    • 22.3.11. Trinity Biotech
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. Strategy Overview
      • 22.3.11.6. Key Developments
      • 22.3.11.7. SWOT Analysis
    • 22.3.12. Alpha-Tec Systems, Inc.
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. Strategy Overview
      • 22.3.12.6. Key Developments
      • 22.3.12.7. SWOT Analysis
    • 22.3.13. Charm Sciences, Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.13.4. Sales Footprint
      • 22.3.13.5. Strategy Overview
      • 22.3.13.6. Key Developments
      • 22.3.13.7. SWOT Analysis
    • 22.3.14. Azer Scientific
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.14.4. Sales Footprint
      • 22.3.14.5. Strategy Overview
      • 22.3.14.6. Key Developments
      • 22.3.14.7. SWOT Analysis
    • 22.3.15. bioBoaVista
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.15.4. Sales Footprint
      • 22.3.15.5. Strategy Overview
      • 22.3.15.6. Key Developments
      • 22.3.15.7. SWOT Analysis
    • 22.3.16. AccuGene
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.16.4. Sales Footprint
      • 22.3.16.5. Strategy Overview
      • 22.3.16.6. Key Developments
      • 22.3.16.7. SWOT Analysis
    • 22.3.17. KSL Diagnostics
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.17.4. Sales Footprint
      • 22.3.17.5. Strategy Overview
      • 22.3.17.6. Key Developments
      • 22.3.17.7. SWOT Analysis
    • 22.3.18. Puritan Medical Products
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.18.4. Sales Footprint
      • 22.3.18.5. Strategy Overview
      • 22.3.18.6. Key Developments
      • 22.3.18.7. SWOT Analysis
    • 22.3.19. Amazing Biotech (Shanghai) Co., Ltd.
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.19.4. Sales Footprint
      • 22.3.19.5. Strategy Overview
      • 22.3.19.6. Key Developments
      • 22.3.19.7. SWOT Analysis

23. Assumptions and Acronyms Used

24. Research Methodology

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제